BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29633238)

  • 21. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
    Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
    Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients.
    Wyen C; Fuhr U; Frank D; Aarnoutse RE; Klaassen T; Lazar A; Seeringer A; Doroshyenko O; Kirchheiner JC; Abdulrazik F; Schmeisser N; Lehmann C; Hein W; Schömig E; Burger DM; Fätkenheuer G; Jetter A
    Clin Pharmacol Ther; 2008 Jul; 84(1):75-82. PubMed ID: 18183034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do activities of cytochrome P450 (CYP)3A, CYP2D6 and P-glycoprotein differ between healthy volunteers and HIV-infected patients?
    Jetter A; Fätkenheuer G; Frank D; Klaassen T; Seeringer A; Doroshyenko O; Kirchheiner J; Hein W; Schömig E; Fuhr U; Wyen C
    Antivir Ther; 2010; 15(7):975-83. PubMed ID: 21041912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inhibition of CYP1A2, CYP2C9, and CYP2D6 by pterostilbene in human liver microsomes.
    Albassam AA; Ahad A; Alsultan A; Yusufoglu HS; Foudah AI; Al-Jenoobi FI
    Pharmazie; 2021 Apr; 76(4):155-158. PubMed ID: 33849700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug Interaction Potential of Osilodrostat (LCI699) Based on Its Effect on the Pharmacokinetics of Probe Drugs of Cytochrome P450 Enzymes in Healthy Adults.
    Armani S; Ting L; Sauter N; Darstein C; Tripathi AP; Wang L; Zhu B; Gu H; Chun DY; Einolf HJ; Kulkarni S
    Clin Drug Investig; 2017 May; 37(5):465-472. PubMed ID: 28155129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of kale ingestion on metabolism by cytochrome P450 enzymes in rats.
    Yamasaki I; Yamada M; Uotsu N; Teramoto S; Takayanagi R; Yamada Y
    Biomed Res; 2012; 33(4):235-42. PubMed ID: 22975634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.
    Lim HK; Duczak N; Brougham L; Elliot M; Patel K; Chan K
    Drug Metab Dispos; 2005 Aug; 33(8):1211-9. PubMed ID: 15860655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses.
    Cusinato DAC; Filgueira GCO; Rocha A; Cintra MACT; Lanchote VL; Coelho EB
    J Pharm Biomed Anal; 2019 Feb; 164():430-441. PubMed ID: 30445356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping.
    Kashuba AD; Nafziger AN; Kearns GL; Leeder JS; Gotschall R; Rocci ML; Kulawy RW; Beck DJ; Bertino JS
    Clin Pharmacol Ther; 1998 Sep; 64(3):257-68. PubMed ID: 9757149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females.
    Wenk M; Todesco L; Krähenbühl S
    Br J Clin Pharmacol; 2004 Apr; 57(4):495-9. PubMed ID: 15025748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity.
    Lesche D; Mostafa S; Everall I; Pantelis C; Bousman CA
    Pharmacogenomics J; 2020 Apr; 20(2):192-201. PubMed ID: 31616047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug metabolism and drug transport of the 100 most prescribed oral drugs.
    Iversen DB; Andersen NE; Dalgård Dunvald AC; Pottegård A; Stage TB
    Basic Clin Pharmacol Toxicol; 2022 Nov; 131(5):311-324. PubMed ID: 35972991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human cytochrome P450 enzymes by Bacopa monnieri standardized extract and constituents.
    Ramasamy S; Kiew LV; Chung LY
    Molecules; 2014 Feb; 19(2):2588-601. PubMed ID: 24566323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity.
    Kvitne KE; Åsberg A; Johnson LK; Wegler C; Hertel JK; Artursson P; Karlsson C; Andersson S; Sandbu R; Skovlund E; Christensen H; Jansson-Löfmark R; Hjelmesaeth J; Robertsen I
    Clin Transl Sci; 2022 Nov; 15(11):2685-2696. PubMed ID: 36037309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Acute Alcohol Exposure on P-Glycoprotein Function at the Blood-Brain Barrier Assessed Using
    Auvity S; Tournier N
    Clin Pharmacol Ther; 2019 Apr; 105(4):812-813. PubMed ID: 30515754
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.
    Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
    J Ethnopharmacol; 2010 Jul; 130(2):275-83. PubMed ID: 20457244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of High-Dose Esomeprazole on CYP1A2, CYP2C19, and CYP3A4 Activities in Humans: Evidence for Substantial and Long-lasting Inhibition of CYP2C19.
    Kaartinen TJK; Tornio A; Tapaninen T; Launiainen T; Isoherranen N; Niemi M; Backman JT
    Clin Pharmacol Ther; 2020 Dec; 108(6):1254-1264. PubMed ID: 32558923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to "Impact of Acute Alcohol Exposure on P-Glycoprotein Function at the Blood-Brain Barrier Assessed Using
    Hsin CH; Fuhr U; Trueck C
    Clin Pharmacol Ther; 2019 Apr; 105(4):814. PubMed ID: 30515759
    [No Abstract]   [Full Text] [Related]  

  • 39. Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6.
    Damkier P; Brøsen K
    Clin Pharmacol Ther; 2000 Aug; 68(2):199-209. PubMed ID: 10976551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of cytochrome P450 isoforms involved in the metabolism of paroxetine and estimation of their importance for human paroxetine metabolism using a population-based simulator.
    Jornil J; Jensen KG; Larsen F; Linnet K
    Drug Metab Dispos; 2010 Mar; 38(3):376-85. PubMed ID: 20007670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.